Search

everythinglearnresearchcommunity

for

Search:↓

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Sonidegib and vismodegib have different side effects and reporting patterns.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Elagolix did not effectively treat polycystic ovary syndrome.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Balancing testosterone may reduce COVID-19 severity.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

PRPF is a safer and more effective treatment for hair loss than PRP.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Polynucleotides effectively promote hair regrowth in androgenetic alopecia without serious side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.